Register Login

Summit Plc (SMMT)

  • Event
  • July 14, 2022, 20:42 UTC

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in patients Trials for Washington Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 3:20 p.m.

    📋 Summit Therapeutics Inc. (SMMT) - Clinical Trial Update

    Filing Date: 2022-07-14

    Accepted: 2022-07-14 16:42:21

    Event Type: Clinical Trial Update

    Event Details:

    Summit Plc (SMMT) Announces Clinical Trial Update Summit Plc (SMMT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: patients, Society
    • Diseases/Conditions: Washington, October
    • Clinical Stage: clinical trial, Phase III
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: Summit

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Summit Plc
    • CIK: 0001599298
    • Ticker Symbol: SMMT
    • Period End Date: 2022-07-14
    • Document Type: 8-K

Search

News categories